A new heterologous fibrin sealant as scaffold to recombinant human bone morphogenetic protein-2 (rhBMP-2) and natural latex proteins for the repair of tibial bone defects

Acta Histochemica

Volumn 117, Issue 3, 2015, Pages 288-296

  Machado, Eduardo Gomes ^a   Issa, João Paulo Mardegan ^b   Figueiredo, Fellipe Augusto Tocchini de ^b   Santos, Geovane Ribeiro dos ^a   Galdeano, Ewerton Alexandre ^a   Alves, Mariana Carla ^a   Chacon, Erivelto Luis ^a   Ferreira Junior, Rui Seabra ^c   Barraviera, Benedito ^c   da Cunha, Marcelo Rodrigues da ^a  

^a School of Physical Education of Jundiaí   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

BMP 2; Fibrin; Natural latex; Protein P 1; Scaffold; Sealant

Indexed keywords

ANTIBIOTIC AGENT; FIBRIN GLUE; HEVEA BRASILIENSIS EXTRACT; LATEX; MOLECULAR SCAFFOLD; OSTEOCALCIN; PARACETAMOL; PLANT EXTRACT; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SNAKE VENOM; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE DEVELOPMENT; BONE REGENERATION; BONE TISSUE; CONTROLLED STUDY; FRACTURE HEALING; HEVEA BRASILIENSIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; METAPHYSIS; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCYTE; OSTEOSYNTHESIS; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SURGICAL INFECTION; TIBIA FRACTURE; TISSUE ENGINEERING; TRABECULAR BONE;

ANIMALIA; HEVEA BRASILIENSIS; RATTUS;

EID: 84955695564     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2015.03.006     Document Type: Article

References (52)

1. Abd-El-Barr M.M., Cox J.B., Antonucci M.U., Bennett J., Murad G.J., Pincus D.W. Recombinant human bone morphogenetic protein-2 as an adjunct for spine fusion in a pediatric population. Pediatr Neurosurg 2011, 47(4):266-271.
2. Abiraman S., Varma H.K., Umashankar P.R., John A. Fibrin glue as an osteoinductive protein in a mouse model. Biomaterials 2002, 23(14):23-31.
3. Alving B.M., Weinstein M.J., Finlayson J.S., Menitove J.E., Fratantoni J.C. Fibrin sealant: summary of a conference on characteristics and clinical uses. Transfusion 1995, 35(9):783-790.
4. Balabanian C.A., Coutinho-Netto J., Lamano-Carvalho T.L., Lacerda S.A., Brentegani L.G. Biocompatibility of natural latex implanted into dental alveolus of rats. J Oral Sci 2006, 48(4):201-205.
5. Barros L.C., Ferreira R.S., Barraviera S.R., Stolf H.O., Thomazini-Santos I.A., Mendes-Giannini M.J., et al. A new fibrin sealant from Crotalus durissus terrificus venom: applications in medicine. J Toxicol Environ Health, B: Crit Rev 2009, 12(8):553-571.
6. Barros L.C., Soares A.M., Costa F.L., Rodrigues V.M., Fuly A.L., Giglio J.R., et al. Biochemical and biological evaluation of gyroxin isolated from Crotalus durissus terrificus venom. J Venomous Anim Toxins Incl Trop Dis 2011, 17(1):23-33.
7. Bessho K., Tagawa T., Murata M. Purification of bone morphogenetic protein derived from bovine bone matrix. Biochem Biophys Res Commun 1989, 165(2):595-601.
8. Borst H.G., Haverich A., Walterbusch G., Maatz W. Fibrin adhesive: an important hemostatic adjunct in cardiovascular operations. J Thorac Cardiovasc Surg 1982, 84(4):548-553.
9. Buser D., Dahlin C., Schenk R.K., Moraes P.B., Filho J.S. Guided bone regeneration in implant dentistry 1996, Quintessence.
10. Carvalho T.L., Araujo C.A., Teofilo J.M., Brentegani L.G. Histologic and histometric evaluation of rat alveolar wound healing around polyurethane resin implants. J Oral Maxillofac Surg 1997, 26(2):149-152.
11. Cheng C., Alt V., Dimitrakopoulou-Strauss A., Pan L., Thormann U., Schnettler R., et al. Evaluation of new bone formation in normal and osteoporotic rats with a 3-mm femur defect: functional assessment with dynamic PET-CT (dPET-CT) using 2-deoxy-2-[18F]fluoro-d-glucose (18F-FDG) and 18F-fluoride. Mol Imaging Biol 2013, 15(3):336-344.
12. de Cunha M.R., Santos A., Goissis G., Genari S. Implants of polyanionic collagen matrix in bone defects of ovariectomized rats. J Mater Sci: Mater Med 2008, 19(3):1341-1348.
13. de Cunha M.R., de Abreu Figueira L., Issa J.P.M., Calzzani R.A.J., do Prado Ribeiro D.C., Iatecola A., et al. Evaluation of the bone repair in defects grafted with hydroxyapatite and collagen membrane combined with laser therapy in rats. J Laser Appl 2011, 23(4).
14. Dal Pizzol M.M., Roggia M.F., Kwitko S., Marinho D.R., Rymer S. Use of fibrin glue in ocular surgery. Braz Arch Ophthalmol 2009, 72(3):308-312.
15. Dubois J.C., Souchier C., Couble M.L., Exbrayat P., Lissac M. An image analysis method for the study of cell adhesion to biomaterials. Biomaterials 1999, 20(19):1841-1849.
16. Duchesne B., Tahi H., Galand A. Use of human fibrin glue and amniotic membrane transplant in corneal perforation. Cornea 2001, 20(2):230-232.
17. Einhorn T.A. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998, 355(Suppl.):S7-S21.
18. Ferraro G.C., Moraes J.R., Shimano A.C., Pereira G.T., Moraes F.R., Bueno de Camargo M.H. Effect of snake venom derived fibrin glue on the tendon healing in dogs: clinical and biomechanical study. J Venomous Anim Toxins Incl Trop Dis 2005, 11:261-274.
19. Ferreira R.S. Autologous or heterologous fibrin sealant scaffold. Which is the better choice?. J Venomous Anim Toxins 2014, 20:31.
20. Franco G.R., Laraia I.O., Maciel A.A., Miguel N.M., Dos Santos G.R., Fabrega-Carvalho C.A., et al. Effects of chronic passive smoking on the regeneration of rat femoral defects filled with hydroxyapatite and stimulated by laser therapy. Injury 2013, 44(7):908-913.
21. Fujimura K., Bessho K., Kusumoto K., Ogawa Y., Iizuka T. Experimental studies on bone inducing activity of composites of atelopeptide type I collagen as a carrier for ectopic osteoinduction by rhBMP-2. Biochem Biophys Res Commun 1995, 208(1):316-322.
22. Gasparotto V.P., Landim-Alvarenga F.C., Oliveira A.L., Simoes G.F., Lima-Neto J.F., Barraviera B., et al. A new fibrin sealant as a three-dimensional scaffold candidate for mesenchymal stem cells. Stem Cell Res Ther 2014, 5(3):78.
23. Gasparotto V.P.O., Alvarenga F.C.L., Oliveira A.L.R., Neto J.F.L., Guastali M.D., Maia L., et al. Viability of fibrin sealant from snake venom as scaffold to rat marrow-derived mesenchymal stem cells. Toxicon 2012, 60(2):108.
24. Gkioni K., Leeuwenburgh S.C., Douglas T.E., Mikos A.G., Jansen J.A. Mineralization of hydrogels for bone regeneration. Tissue Eng B: Rev 2010, 16(6):577-585.
25. Iyomasa M.M., Issa J.P., de Queiroz Tavares M.L., Pereira Y.C., Stuani M.B., Mishima F., et al. Influence of low-level laser associated with osteogenic proteins recombinant human BMP-2 and Hevea brasiliensis on bone repair in Wistar rats. Microsc Res Tech 2012, 75(2):117-125.
26. Kang E.J., Byun J.H., Choi Y.J., Maeng G.H., Lee S.L., Kang D.H., et al. In vitro and in vivo osteogenesis of porcine skin-derived mesenchymal stem cell-like cells with a demineralized bone and fibrin glue scaffold. Tissue Eng A 2010, 16(3):815-827.
27. Kim B.K., Kim S.G., Kim S.Y., Lim S.C., Kim Y.K. A comparison of bone generation capability in rabbits using tooth ash and plaster of Paris with platelet-rich plasma or fibrin sealant. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010, 110(3):8-14.
28. Konig B. Implant and osseointegration 2010, Roca, São Paulo, Brazil. 1st ed.
29. Kram H.B., Bansal M., Timberlake O., Shoemaker W.C. Antibacterial effects of fibrin glue-antibiotic mixtures. J Surg Res 1991, 50(2):175-178.
30. Kram H.B., Ocampo H.P., Yamaguchi M.P., Nathan R.C., Shoemaker W.C. Fibrin glue in renal and ureteral trauma. Urology 1989, 33(3):215-218.
31. Lapchik V.B.V., De Moura Mattaraia V.G., Ko Guimi Care and handling of laboratory animals 2009, Atheneu, São Paulo, Brazil.
32. Lasa C.I., Kidd R.R., Nunez H.A., Drohan W.N. Effect of fibrin glue and opsite on open wounds in DB/DB mice. J Surg Res 1993, 54(3):202-206.
33. Le Nihouannen D., Guehennec L.L., Rouillon T., Pilet P., Bilban M., Layrolle P., et al. Micro-architecture of calcium phosphate granules and fibrin glue composites for bone tissue engineering. Biomaterials 2006, 27(13):2716-2722.
34. Leite C., Naresse L., Arantes H., Lopes A., Thomazini-Santos I., Giannini M., et al. An evaluation by rat colon anastomosis of the efficacy of fibrin glue derived from snake venom. J Venomous Anim Toxins 2000, 6(2):180-193.
35. Lewandrowski K.U., Gresser J.D., Wise D.L., Trantol D.J. Bioresorbable bone graft substitutes of different osteoconductivities: a histologic evaluation of osteointegration of poly(propylene glycol-co-fumaric acid)-based cement implants in rats. Biomaterials 2000, 21(8):757-764.
36. Liu F., Porter R.M., Wells J., Glatt V., Pilapil C., Evans C.H. Evaluation of BMP-2 gene-activated muscle grafts for cranial defect repair. J Orthop Res 2012, 30(7):1095-1102. (Official Publication of the Orthopaedic Research Society).
37. Lacerda C.A.M. Whats is the interest of normal and pathologicalmorphological research to be quantitative? The example of the stereology. Braz J Morphol Sci 1999, 16:131-139.
38. Mainil-Varlet P., Rahn B., Gogolewski S. Long-term in vivo degradation and bone reaction to various polylactides. Biomaterials 1997, 18:257-266.
39. Martinowitz U., Spotnitz W.D. Fibrin tissue adhesives. Thromb Hemost 1997, 78(1):661-666.
40. Nordstron P., Pihlajamaki H., Toivonen T., Tormala P., Rokkanen P. Tissue response to polyglycolide and polylactide pins in cancellous bone. Arch Orthop Trauma Surg 1998, 117:197-204.
41. Okamoto T., Alves-Rezende M.C., Okamoto A.C., Buscariolo I.A., Garcia I.R. Osseous regeneration in the presence of fibrin adhesive material (Tissucol) and epsilon-aminocaproic acid (EACA). Braz Dent J 1995, 6(2):77-83.
42. Paulo N.M., Lima F.G., Siqueira Junior J.T., Fleury L.F., Sant' Ana F.J., Borges A.C., et al. Seringueira's latex membrane (Hevea brasiliensis) with and without polylysine 0.1% and marlex mesh for the reconstruction of iatrogenics abdominal wall defects in rats. Acta Cir Bras 2005, 20(4):305-310.
43. Rahal S.C., Amaral M.S.P., Pai V.D., Barraviera S.R.C.S., Caporal E.H.G., Crocci A.J. Effect of fibrin glue derived from snake venom on the viability of autogenous split-thickness skin graft. J Venomous Anim Toxins Incl Trop Dis 2004, 10:161-172.
44. Rauch F., Lauzier D., Croteau S., Travers R., Glorieux F.H., Hamdy R. Temporal and spatial expression of bone morphogenetic protein-2,-4, and -7 during distraction osteogenesis in rabbits. Bone 2000, 27(3):453-459.
45. Sartori Filho R., Prestes N.C., Thomazini I.A., Mendes-Giannini M.J., Toscanp E., Canavessi A.M.O., et al. Use of fibrin glue derived from snake venom in testicular biopsy of rams. J Venomous Anim Toxins 1998, 4:4.
46. Spector J.A., Luchs J.S., Mehrara B.J., Greenwald J.A., Smith L.P., Longaker M.T. Expression of bone morphogenetic proteins during membranous bone healing. Plast Reconstr Surg 2001, 107(1):124-134.
47. Stewart R., Goldstein J., Eberhardt A., Chu G.T., Gilbert S. Increasing vascularity to improve healing of a segmental defect of the rat femur. J Orthop Trauma 2011, 25(8):472-476.
48. Thomazini-Santos I.A., Barraviera S.R.C.S., Mendes-Giannini M.J.S., Barraviera B. Surgical adhesives. J Venomous Anim Toxins 2001, 7(2):159-171.
49. Thormann U., Khawassna T.E., Ray S., Duerselen L., Kampschulte M., Lips K., et al. Differences of bone healing in metaphyseal defect fractures between osteoporotic and physiological bone in rats. Injury 2014, 45(3):487-493.
50. Usas A., Ho A.M., Cooper G.M., Olshanski A., Peng H., Huard J. Bone regeneration mediated by BMP4-expressing muscle-derived stem cells is affected by delivery system. Tissue Eng, A 2009, 15(2):285-293.
51. Wagner W., Wiltfang J., Pistner H., Yildirim M., Ploder B., Chapman M., et al. Bone formation with a biphasic calcium phosphate combined with fibrin sealant in maxillary sinus floor elevation for delayed dental implant. Clin Oral Implants Res 2012, 23(9):1112-1117.
52. Welldon K.J., Findlay D.M., Evdokiou A., Ormsby R.T., Atkins G.J. Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers. Mol Cell Endocrinol 2013, 376:85-92.